In gastric cancer, SP1 transcriptionally regulates ATXN2 expression, activating the PI3K/AKT signaling pathway, which contributes to ATXN2's anti-apoptotic and chemoresistant properties in gastric cancer. The gene discussed is SP1; the disease is gastric cancer.